hme

Matthew Krebs

United Kingdom
Matthew Krebs
Matthew Krebs

United Kingdom

Expert bio

Dr Matthew Krebs is Clinical Senior Lecturer in Experimental Cancer Medicine and Honorary Consultant in Medical Oncology at The Christie NHS Foundation Trust, Manchester, UK.

Dr Krebs’ expertise is in early-phase clinical trials with focus on drug development for lung cancer and precision medicine. His research focuses on personalised medicine, translational circulating biomarkers and clinical application of novel biomarkers in guiding treatment selection. He has extensive experience in early phase clinical trials involving first in-human therapies and novel combinations and served as Principal or Chief Investigator in over 45 phase I trials, whilst acting as co-investigator in over 80 studies spanning a wide range of novel therapies and indications. Dr Krebs has authorship in more than 50 peer-reviewed publications and over 100 conference abstracts, with writings in non-small lung cancer including topics such as: immuno-oncology, EGFR TKIs, novel targeted therapies and clinical utility of circulating biomarkers.

Dr Krebs is Lead for Precision Medicine with The Christie NHS Foundation Trust’s Experimental Cancer Medicine Team, Chief Investigator of the TARGET Precision Medicine Program, and Chair of the Manchester Molecular Tumour Board. He is Cancer Genomics Medical Lead within the North West Genomics Laboratory Hub in the UK and clinical trials theme sub-lead within the Cancer Research UK Manchester-UCL Lung Cancer Centre of Excellence.

EM-87466 - Date of preparation: January 2022

MORE INFORMATION
You can see my upcoming and previous webinars here.